All Articles

Call Back: Using the Phone to Promote Adherence to Oral Antineoplastic Agents

By Rachel M. Akerley, MSN, RN, OCN; Cherry Karl, PhD, CNE

Original Research

June 2021 Vol 12, No 6

Have you overlooked this simple and effective tool in your practice?

The Navigation Metrics Toolkit: Measuring the Effectiveness of Your Navigation Program

Interview with the Innovators

June 2021 Vol 12, No 6

Not sure how to capture the data you need to assess your navigation program?

We’ve got you covered with our AONN+ Metrics Toolkit.

AONN+ Navigation Metrics Toolkit: The Community Healthcare System Experience

Interview with the Innovators

June 2021 Vol 12, No 6

Melissa Plavsa wanted to strengthen her navigation program. Here’s how she did it.

Physical, Psychological, Social, and Spiritual Well-Being of Patients with Chronic Lymphocytic Leukemia and Their Caregivers: A Scoping Review

By Emily Gentry, RN, BSN, HON-ONN-CG, OCN; Chelsea Passwater, DNP, APRN, AGCNS-BC, OCN; Nikki Barkett, BSN, RN, OCN

Chronic Lymphocytic Leukemia

June 2021 Vol 12, No 6

Chronic lymphocytic leukemia (CLL) is the most common leukemia among adults, with an estimated 21,250 new cases and 4320 attributed deaths in 2021.

How to Start Survivorship Care at the Time of Diagnosis

By Cheryl Bellomo, MSN, RN, HON-ONN-CG, OCN

June 2021 Vol 12, No 6

10 clever ways for patients to engage in survivorship care and 3 important ways for you to advocate for their rights.

The Impact of New Driver Mutations on Treatment of NSCLC

Best Practices in Lung Cancer Navigation

The Impact of New Driver Mutations on Treatment of NSCLC

By Lauren Welch, MSN, NP-C, AOCNP

Interview with the Innovators

Identification of new actionable targets and driver mutations have revolutionized the treatment of NSCLC

Educating Patients About the Need to Wait for Biomarker Test Results

Best Practices in Lung Cancer Navigation

Educating Patients About the Need to Wait for Biomarker Test Results

By Kammi Fox-Kay, MSN, RN, AOCNS, ONN-CG(T); Cathy Simmons, RN, BSN, ONN-CG(T); Lauren Welch, MSN, NP-C, AOCNP

Interview with the Innovators

Waiting for biomarker test results ensures the best outcomes in NSCLC.

Explaining the Treatment Trajectory in NSCLC

Best Practices in Lung Cancer Navigation

Explaining the Treatment Trajectory in NSCLC

By Kammi Fox-Kay, MSN, RN, AOCNS, ONN-CG(T); Cathy Simmons, RN, BSN, ONN-CG(T); Lauren Welch, MSN, NP-C, AOCNP

Interview with the Innovators

Describing the road map of the cancer care journey in NSCLC.

The Multidisciplinary Care Approach to Cancer Care Management

Best Practices in GU Navigation

The Multidisciplinary Care Approach to Cancer Care Management

By Megan Price, MSN, APRN, FNP-C; Virginia Seery, CRNP, MSN; Laura Wood, RN, MSN, OCN

Interview with the Innovators

There are an ever-growing number of treatment options that are contributing to more successful outcomes and higher survival rates for cancer patients. The number of care providers that cancer patients need during their journey is also expanding. Please join Laura Wood, RN, MSN, OCN, and Virginia Seery, MSN, RN, ANP-BC, AOCNP, as they discuss the role of the multidisciplinary care team approach to deliver the best possible treatment for cancer patients.

American Cancer Society Cancer Action Network Releases Recommendations to Increase Cancer Biomarker Testing

The American Cancer Society Cancer Action Network has published data that demonstrate there are multiple barriers to biomarker testing access and released recommendations that address these barriers.

Page 105 of 283

SUBSCRIBE